# Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib

> **NCT06461078** · PHASE1 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Drug Kinetics

## Interventions

- **DRUG:** Radotinib HCl

## Key facts

- **NCT ID:** NCT06461078
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-22
- **Primary completion:** 2024-09-25
- **Final completion:** 2025-04-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461078, "Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06461078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*